Litcius/Paper detail

Developing patient-derived organoids to predict PARP inhibitor response and explore resistance overcoming strategies in ovarian cancer

Mengyu Tao, Fan Sun, Juan Wang, Yujing Wang, Hongrui Zhu, Meiqi Chen, Liyun Liu, Li Liu, Hou‐Wen Lin, Xia Wu

2022Pharmacological Research36 citationsDOI

Topics & Concepts

OlaparibPARP inhibitorDrug resistanceOvarian cancerMedicineCancer researchCancerPoly ADP ribose polymeraseBiologyPolymeraseInternal medicineGeneticsDNAPARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentDNA Repair Mechanisms